X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Next-Generation Immunology Drugs Companies

This report lists the top Next-Generation Immunology Drugs companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Next-Generation Immunology Drugs industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Next-Generation Immunology Drugs Top Companies

  1. Abbvie

  2. Novartis

  3. GlaxoSmithKline

  4. Pfizer

  5. Bristol-Myers Squibb

*Disclaimer: Top companies sorted in no particular order

Next-Generation Immunology Drugs Market Major Players

Next-Generation Immunology Drugs Market Concentration

Next-Generation Immunology Drugs  Market Concentration

Next-Generation Immunology Drugs Company List

                            • Pfizer Inc

                            • Abbvie Inc.

                            • Johnson and Johnson

                            • F. Hoffmann-La Roche Ltd.

                            • Amgen Inc.

                            • Novartis AG

                            • Astellas Pharma Inc.

                            • UCB SA

                            • Bristol-Myers Squibb Company

                            • Merck & Co., Inc.

                            • Eli Lilly and Company


                        Specific to Next-Generation Immunology Drugs Market
                        Need More Details On Market Players And Competitors?
                        Download PDF

                        Next-Generation Immunology Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)